Johnson & Johnson‘s (NYSE:JNJ) Innovation JJDC investment arm this week led a $35 million funding round for sleep-focused neurotechnology company Dreem. San Francisco-based Dreem is developing a number of devices focused on addressing sleep problems, including a headband designed to both monitor brain activity to track sleep accurately and use auditory stimulation to aid in […]